Status | Study |
Completed |
Study Name: Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2022-06-24 Interventions: Interventional |
RECRUITING |
Study Name: PET Image in PAH Patients Condition: Pulmonary Arterial Hypertension Date: 2022-06-09 Interventions: PET/CT Imaging: The duration of PET will be around 90 minutes.Women should have negative pregnancy test prior to the study.An arteria |
RECRUITING |
Study Name: Effect of CS1 in Subjects With Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2022-01-17 Interventions: CS1 delayed-release capsules will be supplied with 160 mg active pharmaceutical ingredient (sodium valproate) per capsule.Three dose levels that |
ACTIVE_NOT_RECRUITING |
Study Name: Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin Condition: Pulmonary Arterial Hypertension Date: 2021-04-06 Interventions: Participants on the study will receive Remodulin via the Remunity Pump with dosing and titration managed at the discretion of the prescribing healthca |
NOT_YET_RECRUITING |
Study Name: Pilot Randomized Trial of Ambulatory Exercise in Pulmonary Hypertension Condition: Pulmonary Arterial Hypertension Date: 2020-02-02 Interventions: Usual care |
RECRUITING |
Study Name: Olaparib for PAH: a Multicenter Clinical Trial Condition: Pulmonary Arterial Hypertension Date: 2018-12-17 Interventions: Olaparib up to 300 mg BID for 24 weeks |
RECRUITING |
Study Name: A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) Condition: Pulmonary Arterial Hypertension Date: 2016-10-12 Interventions: Dispersible tablet; Oral use |
RECRUITING |
Study Name: Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA) Condition: Pulmonary Arterial Hypertension Date: 2016-06-21 Interventions: Right ventricular contouring and indexed aortic flow measurement from cMRI will be performed locally with the dedicated software used in clinical p |
Recruiting |
Study Name: REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension Condition: Pulmonary Arterial Hypertension Date: 2014-12-04 Interventions: Drug: Macitentan All patients take open-label macitentan 10mg o.d. |
Completed |
Study Name: Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2014-08-30 Interventions: Interventional |